Türkiye entered the second half of 2026 with sustained international patient demand, continued investment in healthcare services, and a stronger emphasis on quality, regulation, and long-term competitiveness, according to official data and industry developments.
Türkiye medical tourism maintained positive momentum entering the second half of 2026. Official figures show that 302,487 international patients generated approximately $761.5 million in revenue during the first quarter of the year. Alongside continued patient demand, healthcare providers are placing greater emphasis on accreditation, patient safety, digital engagement, and continuity of care as competition in the global medical tourism market evolves.
Türkiye entered the second half of 2026 as one of the major destinations for international patients seeking cross-border healthcare, supported by competitive treatment costs, modern healthcare infrastructure, experienced physicians, and extensive international flight connectivity.
According to International Health Services Inc. (USHAŞ), an affiliate of Türkiye’s Ministry of Health, 302,487 international patients received healthcare services in Türkiye during the first quarter of 2026, generating approximately $761.5 million in medical tourism revenue.
As of early August 2026, official statistics covering the entire first half of the year had not yet been published. Nevertheless, the available first-quarter data indicate that international demand for healthcare services remained strong entering the second half of the year.
International patient demand remains diverse
Türkiye continues to attract patients seeking a broad range of medical services, including hair transplantation, cosmetic surgery, dentistry, ophthalmology, bariatric surgery, fertility treatment, orthopedics, oncology, cardiovascular care, and organ transplantation.
Its geographic location, relatively short travel times from key source markets, internationally experienced healthcare professionals, and integrated treatment packages continue to support its appeal among patients from Europe, the Middle East, Central Asia, Africa, and neighboring regions.
Quality increasingly influences patient choice
While competitive pricing remains an important advantage, many healthcare providers are placing greater emphasis on internationally recognized accreditation, physician expertise, multilingual patient services, transparent communication, and documented quality standards.
Industry observers note that international patients are increasingly evaluating treatment quality, institutional reputation, and clinical experience alongside affordability when selecting destinations for medical care.
Regulatory oversight continues to evolve
Türkiye has continued strengthening its regulatory framework for international health tourism through updated authorization requirements and oversight of healthcare providers and intermediary organizations serving international patients.
The evolving regulatory framework is intended to improve transparency, reinforce patient protection, and support internationally recognized quality standards across the sector.
Digital engagement becomes increasingly important
Digital communication now plays a central role in the international patient journey.
Many healthcare providers have expanded multilingual websites, online consultations, digital appointment systems, and remote communication tools to improve patient access before and after treatment.
Healthcare organizations are also placing greater emphasis on providing accurate information online, reflecting increased regulatory attention to healthcare promotion and patient communication.
Greater focus on continuity of care
Many providers have increased their focus on post-treatment support, follow-up consultations, remote communication, and coordination with healthcare professionals in patients’ home countries.
These services are becoming increasingly important for international patients undergoing procedures that require extended recovery or long-term monitoring and may influence patient satisfaction and institutional reputation.
Outlook for the remainder of 2026
The outlook for the rest of 2026 will depend on international travel conditions, geopolitical developments, healthcare demand, and the continued implementation of regulatory reforms.
Although complete first-half statistics have yet to be released, current official data suggest that Türkiye’s medical tourism sector continues to evolve toward a model that places greater emphasis on quality, patient safety, transparency, and sustainable long-term growth.
Why It Matters
Medical tourism remains one of Türkiye’s most valuable service export industries, generating foreign currency income while supporting investment in healthcare infrastructure, advanced medical technologies, and highly skilled healthcare professionals. As international competition continues to intensify, sustained growth is likely to depend increasingly on quality assurance, patient safety, regulatory compliance, transparency, and trusted clinical outcomes.
Frequently Asked Questions
How many international patients received healthcare in Türkiye during 2026?
According to official USHAŞ data, 302,487 international patients received healthcare services during the first quarter of 2026. Consolidated figures for the first half of the year had not yet been published.
Which medical services attract international patients?
Hair transplantation, cosmetic surgery, dentistry, ophthalmology, bariatric surgery, fertility treatment, orthopedics, oncology, cardiovascular care, and organ transplantation remain among Türkiye’s principal medical tourism specialties.
How is regulation changing the sector?
Updated regulations strengthen authorization requirements, improve transparency, reinforce patient protection, and support quality standards for healthcare institutions and intermediary organizations serving international patients.
What trends are expected to shape the industry during the remainder of 2026?
Industry observers expect quality assurance, accreditation, digital patient engagement, continuity of care, regulatory compliance, and international travel conditions to remain among the principal factors influencing the sector’s development.
Source: International Health Services Inc. (USHAŞ), Ministry of Health of Türkiye, Turkish Statistical Institute (TurkStat)
